Palo Alto Medical Foundation
Palo Alto Medical Foundation
Palo Alto, California, United States4 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 1 Study of C.001 in Retinal Degeneration | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Geographic Atrophy, Stargardt disease, age-related macular degeneration, eye disorder, hereditary disease, macular degeneration, retinal degeneration, retinal disorder | Recruiting | Phase 1 | 2026-08-17 | NCT07594236 | |
| Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01) | Adnexal Diseases, Carcinoma, Ovarian Epithelial, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, carcinoma, endocrine system disorder, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder | Recruiting | Phase 3 | 2026-07-02 | NCT06819007 | |
| PATHFINDER 2: A Multi-Cancer Early Detection Study | cancer, neoplasm | Active, not recruiting | Not applicable | 2026-05-14 | NCT05155605 | |
| Clinical Outcomes of Clareon Vivity Intraocular Lens With Mini-Monovision Approach | Aphakia, Aphakia, Postcataract, eye disorder, lens disorder | Active, not recruiting | Not applicable | 2025-07-04 | NCT05821101 |